Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse
Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
A look into the IAM back catalogue to see how we have covered the developing face of IP strategy in one of the world's great innovation powers Read more
A UK Supreme Court justice, a former USPTO acting director, a globally-renowned IP scholar, a trailblazing trademark lawyer and a one-time presidential candidate form the class of 2020 Read more
First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more
Leading in-house and private practice lawyers share their experiences of working in the shadow of a pandemic and explain what they believe might happen next Read more
Despite the improving Chinese IP environment and trade deal commitments, long-term personal relationships are likely to be increasingly important in getting transactions over the line Read more
Ian McClure explains why the current covid-19 crisis could herald a revolution in the academic institutions’ licensing efforts, but also warns of potential dangers ahead Read more
The agency's former Commissioner of Patents says it’s so far so good at the office - but explains why a backlog may build at the end of the year Read more
“We are only in the position to tackle the pandemic, because of where the system has brought us so far,” says Corey Salsberg in an exclusive interview with IAMRead more
Mobile devices will play a major role in the recovery from the covid-19 crisis - and that means how much they cost is going to come firmly under the microscope Read more
Free webinar next Tuesday will focus on findings of exclusive survey of corporate IP leaders and strategies to maximise the reach and value of holdings as cost-effectively as possible Read more
The amazing technologies that power the internet have kept us connected as the covid-19 pandemic has raged. This connectivity is down to the investments and contributions made by patent owners Read more
February lockdown cratered CNIPA applications, but March brought a significant rebound as Beijing-based patent agencies and law firms began to approach normal capacity Read more
The state-backed patent funds helped change the culture around patents in the South Korea and Japan, and now both face the task of surviving the private sector Read more
A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck Read more
@IAM_magazine RT @jwschindler: Dong clarified that the troll moniker (专利流氓) could apply to both NPEs and 'malicious' infringers. Measures she reportedly… Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
